financetom
Business
financetom
/
Business
/
Astrotech Names Jennifer Canas CFO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Astrotech Names Jennifer Canas CFO
May 28, 2025 2:59 PM

05:41 PM EDT, 05/28/2025 (MT Newswires) -- Astrotech ( ASTC ) said late Wednesday it has appointed Jennifer Canas as chief financial officer, effective May 22.

Canas who has held the position of Astrotech's ( ASTC ) Corporate Controller since June 2022, brings more than two decades of senior-level financial experience to the role, the company said.

The company disclosed in a regulatory filing that the board removed Ryan Polk from his positions as CFO, Treasurer and Secretary of the company.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bitfarms Appoints Former Amazon Web Services Executive Wayne Duso to Board
Bitfarms Appoints Former Amazon Web Services Executive Wayne Duso to Board
Aug 18, 2025
07:58 AM EDT, 08/18/2025 (MT Newswires) -- Bitfarms ( BITF ) , a global energy and compute infrastructure company, on Monday said it appointed Wayne Duso to the board. With the appointment of Duso, who most recently spent 12 years as an executive at Amazon Web Services, the board is now comprised of seven directors, six of whom are independent....
180 Degree Capital, Mount Logan Revise Merger Terms
180 Degree Capital, Mount Logan Revise Merger Terms
Aug 18, 2025
07:57 AM EDT, 08/18/2025 (MT Newswires) -- 180 Degree Capital ( TURN ) and Mount Logan Capital said Monday that their boards of directors have revised their merger agreement to provide 180 Degree shareholders a higher number of shares of the merged company. The companies said 180 Degree Capital ( TURN ) shareholders will now receive shares of the combined...
Unicycive Wins US Patent for Kidney Disease Drug
Unicycive Wins US Patent for Kidney Disease Drug
Aug 18, 2025
07:57 AM EDT, 08/18/2025 (MT Newswires) -- Unicycive Therapeutics ( UNCY ) said Monday it received a US patent for UNI-494 to treat chronic kidney disease, following an earlier patent covering acute kidney injury. The drug has completed a phase 1 trial in healthy volunteers and holds orphan drug designation for preventing delayed graft function in kidney transplant patients, the...
Aptose Biosciences Reports Early Positive Tuspetinib Safety Data Across Newly Diagnosed AML Patients
Aptose Biosciences Reports Early Positive Tuspetinib Safety Data Across Newly Diagnosed AML Patients
Aug 18, 2025
08:01 AM EDT, 08/18/2025 (MT Newswires) -- Aptose Biosciences ( APTOF ) on Monday said the latest data update from the Phase 1/2 Tuscany trial in newly diagnosed acute myeloid leukemia (AML) patients show no significant safety concerns with different dose levels of the company's lead candidate, tuspetinib. The trial was initiated last December. Data from 10 patients across all...
Copyright 2023-2026 - www.financetom.com All Rights Reserved